The role played by interleukin-10 in cytokine and chemokine dysregulation during secondary pneumococcal pneumonia after influenza

Journal of Infectious Diseases

Volumn 199, Issue 10, 2009, Pages 1555-1556

  Cao, Ju ^a   Gong, Yi ^a   Yin, Yibing ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLTRYPTOPHAN; AMPICILLIN; AZITHROMYCIN; CLINDAMYCIN; INDOLEAMINE 2,3 DIOXYGENASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; BACTERIAL OVERGROWTH; CYTOKINE PRODUCTION; INFECTION SENSITIVITY; INFLUENZA; LETTER; NONHUMAN; PRIORITY JOURNAL; SECONDARY INFECTION; STREPTOCOCCUS PNEUMONIA; TREATMENT OUTCOME;

ANIMALS; CHEMOKINES; CYTOKINES; HUMANS; INFLAMMATION; INFLUENZA, HUMAN; INTERLEUKIN-10; MICE; MODELS, ANIMAL; PNEUMONIA, PNEUMOCOCCAL;

EID: 65549087170     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/598608     Document Type: Letter

References (5)

1. Karlström Å, Boyd KL, English BK, McCullers JA. Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza. J Infect Dis 2009; 199:311-9.
2. van der Sluijs KF, Van Elden LJR, NijhuisM, et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol 2004; 172:7603-9.
3. van der Sluijs KF, Nijhuis M, Levels JHM, et al. Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. J Infect Dis 2006; 193:214-22.
4. Smith MW, Schmidt JE, Rehg JE, Orihuela C, McCullers JA. Induction of pro-and antiinflammatory molecules in a mouse model of pneumococcal pneumonia following influenza. Comp Med 2007; 57:82-9.
5. Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol 2008; 180:5771-7.